Business News • PR NewsWire • Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products

Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products

Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products

REDWOOD CITY, Calif., May 5, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. made three presentations at the Respiratory Drug Delivery Europe (RDD Europe 2011) meeting in Berlin this week elucidating the tunability, versatility and universality of the Company's porous particle-based metered dose inhale

View More : http://www.prnewswire.com/news-releases/pearl-therapeutics-highlights-its-porous-particle-cosuspension-platform-demonstr...

Releted News by prnewswire

PwC Addresses Vital Elements of Managing Talent to Deliver Business Results at SuccessFactors' SuccessConnect San Francisco 2011

Heska Announces Q1 2011 Results

Psychemedics Corporation Announces First Quarter Profits

Gruposura Obtains a Second International Investment Grade, this Time from Standard & Poor`s